Journal ArticleOPEN ACCESS

Aripiprazole versus brexpiprazole for people with schizophrenia

Cochrane Database of Systematic Reviews (2023) 2023(2)
DOI: 10.1002/14651858.CD014670
2Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. To assess the efficacy and tolerability of aripiprazole compared to brexpiprazole in people diagnosed with schizophrenia or schizophrenia-like psychosis.

Cite

CITATION STYLE

APA

Martínez-Vélez, N. A., Escamilla Orozco, R. I., Flores Medina, Y., Saracco-Alvarez, R. A., Rosel Vales, M., Aguilar-Salas, I., & Sánchez-Hernández, G. Y. (2023). Aripiprazole versus brexpiprazole for people with schizophrenia. Cochrane Database of Systematic Reviews, 2023(2). https://doi.org/10.1002/14651858.CD014670

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free